GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Proteomics International Laboratories Ltd (ASX:PIQ) » Definitions » PB Ratio

Proteomics International Laboratories (ASX:PIQ) PB Ratio : 23.86 (As of May. 15, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Proteomics International Laboratories PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-15), Proteomics International Laboratories's share price is A$1.05. Proteomics International Laboratories's Book Value per Share for the quarter that ended in Dec. 2023 was A$0.04. Hence, Proteomics International Laboratories's PB Ratio of today is 23.86.

The historical rank and industry rank for Proteomics International Laboratories's PB Ratio or its related term are showing as below:

ASX:PIQ' s PB Ratio Range Over the Past 10 Years
Min: 3.45   Med: 11.53   Max: 35.94
Current: 23.86

During the past 9 years, Proteomics International Laboratories's highest PB Ratio was 35.94. The lowest was 3.45. And the median was 11.53.

ASX:PIQ's PB Ratio is ranked worse than
96.52% of 1320 companies
in the Biotechnology industry
Industry Median: 2.52 vs ASX:PIQ: 23.86

During the past 12 months, Proteomics International Laboratories's average Book Value Per Share Growth Rate was -29.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 12.90% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 2.40% per year.

During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of Proteomics International Laboratories was 32.20% per year. The lowest was -4.70% per year. And the median was 15.05% per year.

Back to Basics: PB Ratio


Proteomics International Laboratories PB Ratio Historical Data

The historical data trend for Proteomics International Laboratories's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proteomics International Laboratories PB Ratio Chart

Proteomics International Laboratories Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
PB Ratio
Get a 7-Day Free Trial Premium Member Only 9.46 8.75 12.85 29.06 12.46

Proteomics International Laboratories Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.41 29.06 15.32 12.46 20.34

Competitive Comparison of Proteomics International Laboratories's PB Ratio

For the Biotechnology subindustry, Proteomics International Laboratories's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Proteomics International Laboratories's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Proteomics International Laboratories's PB Ratio distribution charts can be found below:

* The bar in red indicates where Proteomics International Laboratories's PB Ratio falls into.



Proteomics International Laboratories PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Proteomics International Laboratories's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=1.05/0.044
=23.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Proteomics International Laboratories  (ASX:PIQ) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Proteomics International Laboratories PB Ratio Related Terms

Thank you for viewing the detailed overview of Proteomics International Laboratories's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Proteomics International Laboratories (ASX:PIQ) Business Description

Traded in Other Exchanges
N/A
Address
6 Verdun Street, QEII Medical Centre, QQ Block, Nedlands, Perth, WA, AUS, 6009
Proteomics International Laboratories Ltd is a biological research and drug discovery company. The company specializes in the area of proteomics which is the industrial-scale study of the structure and function of proteins. Its operations are divided into PromarkerD which targets the diabetes epidemic and is a predictive diagnostic test for diabetic kidney disease, a progressive disorder found in one in three adults with diabetes; its proprietary biomarker discovery platform called Promarker, which searches for protein fingerprints in a sample; and Analytical Services that are specialist contract research focusing on biosimilars quality control and pharmacokinetic testing for clinical trials.

Proteomics International Laboratories (ASX:PIQ) Headlines

No Headlines